Tranquillizers
Tranquillizers are a class of pharmacological agents that are used to reduce anxiety, induce calmness, and promote sleep. These substances can be divided into two main categories: major tranquillizers, also known as antipsychotics, and minor tranquillizers, often referred to as anxiolytics or sedatives. The use of tranquillizers has become widespread in the management of various mental health conditions, including anxiety disorders, insomnia, and certain cases of schizophrenia and other psychotic disorders.
Major Tranquillizers[edit | edit source]
Major tranquillizers, or antipsychotics, are primarily used in the treatment of psychotic disorders. They work by altering the effects of neurotransmitters in the brain, particularly dopamine, which is thought to be involved in the pathophysiology of psychosis. Major tranquillizers can be further classified into two groups: typical antipsychotics, also known as first-generation antipsychotics, and atypical antipsychotics, or second-generation antipsychotics. Typical antipsychotics, such as haloperidol and chlorpromazine, have been in use since the mid-20th century, while atypical antipsychotics, like risperidone and olanzapine, were developed more recently and are often preferred due to their lower risk of side effects.
Minor Tranquillizers[edit | edit source]
Minor tranquillizers, or anxiolytics, are used to treat anxiety and insomnia. They include substances such as benzodiazepines, which are effective in reducing anxiety and promoting sleep but have a potential for addiction and withdrawal symptoms. Benzodiazepines, such as diazepam (Valium) and lorazepam (Ativan), act on the GABA neurotransmitter system, enhancing its inhibitory effects and thus producing a calming effect. Other minor tranquillizers include buspirone, which is used specifically for anxiety and has a lower risk of dependence.
Indications and Use[edit | edit source]
Tranquillizers are indicated for the treatment of a variety of conditions, including anxiety disorders, acute stress reactions, insomnia, and certain psychotic disorders. Their use must be carefully managed due to the risks of side effects, dependence, and withdrawal. In the case of benzodiazepines, guidelines recommend short-term use to minimize the risk of addiction.
Side Effects and Risks[edit | edit source]
The use of tranquillizers is associated with a range of side effects. For major tranquillizers, these can include extrapyramidal symptoms, tardive dyskinesia, and weight gain, particularly with atypical antipsychotics. Minor tranquillizers, particularly benzodiazepines, can cause drowsiness, confusion, and impaired coordination, increasing the risk of accidents. Long-term use can lead to tolerance, dependence, and withdrawal symptoms upon cessation.
Conclusion[edit | edit source]
Tranquillizers play a vital role in the management of anxiety, insomnia, and psychotic disorders. However, their use must be carefully balanced against the potential for side effects and dependence. Ongoing research into safer and more effective treatments continues to evolve the field of psychopharmacology.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD